EN DE

Top Glove Corporation (TGLVY) Fair Value & Analysis

Healthcare · US · Market cap $1.4B

TG Top Glove Corporation logo Top Glove Corporation TGLVY · US
Price$0.5775
Fair Value$0.2900
Upside-49.8%
Quality46/100
Watch Top Glove Corporation for free, get notified when fair value or trend changes. Watch for free
Evidence: High Range $0.1900 – $0.3700 📤 Share as image

Fair value as of: Jul 21, 2026

From 26 valuation models · updated 4 days ago

Fair value updated Jul 21, 2026, revised from $0.3500 to $0.2900 (−17.1%) since Jun 24, 2026. Share price −17.9% over the past month.

Price vs Fair Value (12 months)

$1.26 $0.4598 Fair Value $0.2900 Aug 2024 Jul 2026

12‑month range $0.4598 – $1.26 · fair‑value band $0.1900 – $0.3700 · the $0.5775 price screens above the $0.2900 fair value. As of Jul 21, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Top Glove Corporation (TGLVY) currently trades at $0.5775, while our model-based Fair Value estimate is $0.2900, implying the stock looks roughly 49.8% overvalued today. We read business quality at 46/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Top Glove Corporation generated revenue of $3.9B at a net margin of 4.8%. Revenue grew 31.9% year over year. It earns a return on equity of 3.8%. Net debt stands at $551M. Fundamentals as of Jul 21, 2026

Our scenario range runs from $0.1900 (bear case) to $0.3700 (bull case); at $0.5775, the current price sits above that range. The share trades about 38% below its 52-week high and 26% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -42% fair-value upside, at -50%, TGLVY screens richer than that median.

Key figures & financial health

Revenue (TTM) $3.9B
Revenue growth (YoY) +31.9%
Net margin 4.8%
Return on equity 3.8%
Free cash flow $156M FY2025
P/E ratio 35.7
More key figures
Operating margin 13.7%
EPS (TTM) $0.0200
Dividend yield 0.7%
EPS growth (YoY) +135%
Net debt $551M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 21, 2026. TTM = trailing twelve months.

About the company

Top Glove Corporation Bhd., an investment holding company, engages in the manufacture, trade, and sale of gloves in Malaysia, Thailand, the People's Republic of China, and internationally. It offers nitrile, latex, surgical, rubber, examination, medical, and vinyl gloves; concentrate and synthetic latex, formers, chemicals and chemical compounds, rubber dental dams, exercise bands, condoms, and rubber related products; packaging materials, boxes, and cartons; and disposable and medical face masks, engineering parts and rubber glove machinery, functional fillers, healthcare products, and home care and personal care products. The company also provides property investment and consultancy services, and electrical engineering works; clinical and specialist medical services; analytical, medical related consultancy, emergency medical, advisory, accommodation, management and trading, and value added services; financial and treasury services; management services in plantation sector; …

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Top Glove Corporation reported revenue of $3.5B in FY2025 versus $16.4B in FY2021, a compound −32.0%/yr. Reported net income was $132M in FY2025, compounding −63.9%/yr from FY2021.

Revenue −32.0%/yr
FY21 $16.4B
FY22 $5.6B
FY23 $2.3B
FY24 $2.5B
FY25 $3.5B
Net income −63.9%/yr
FY21 $7.8B
FY22 $276M
FY23 −$879M
FY24 −$18.3M
FY25 $132M

Is TGLVY fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Top Glove Corporation Fair Value". https://www.fairvalue-calculator.com/stock/TGLVY

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).

Stock Price Fair Value vs Fair Value
Intuitive Surgical, Inc ISRG C$20.93 C$6.03 -71%
EssilorLuxottica Société anonyme ESLOF $205.86 $114.90 -44%
Medline Inc MDLN $36.54 $30.66 -16%
HOYA Corporation HOCPY $178.46 $103.27 -42%
Becton, Dickinson and Company BDX $149.56 $117.04 -22%
Alcon Inc ALC $66.11 $36.99 -44%
ResMed Inc RMD $196.04 $185.14 -6%
West Pharmaceutical Services, Inc WST $314.50 $120.69 -62%
Terumo Corporation TRUMF $14.62 $12.65 -13%
Straumann Holding SAUHY $13.07 $5.51 -58%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Top Glove Corporation (TGLVY) undervalued?
As of Jul 21, 2026, our model estimates a fair value of $0.2900 versus a price of $0.5775, about −50% (overvalued). Model-based estimate, not financial advice.
What is the fair value of TGLVY?
Our model-based fair value for Top Glove Corporation is $0.2900 (as of Jul 21, 2026), built from audited fundamentals. The current price is $0.5775.
What is the quality score of TGLVY?
Top Glove Corporation has a Quality Score of 46/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Top Glove Corporation (TGLVY)?
Top Glove Corporation reported trailing-twelve-month revenue of about $3.9B (latest available figure, as of Jul 21, 2026).
What is the net profit margin of TGLVY?
The net profit margin of Top Glove Corporation is about 4.8%, meaning it keeps roughly 4.8% of revenue as net income. Based on the latest reported figures.
Does Top Glove Corporation pay a dividend?
Top Glove Corporation currently shows a dividend yield of about 0.66% relative to its recent price (as of Jul 21, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Unlock the full Top Glove Corporation analysis, and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.